490 reports of this reaction
3.1% of all ANTI THYMOCYTE GLOBULIN (RABBIT) reports
#3 most reported adverse reaction
DRUG INEFFECTIVE is the #3 most commonly reported adverse reaction for ANTI THYMOCYTE GLOBULIN (RABBIT), manufactured by Genzyme Corporation. There are 490 FDA adverse event reports linking ANTI THYMOCYTE GLOBULIN (RABBIT) to DRUG INEFFECTIVE. This represents approximately 3.1% of all 15,925 adverse event reports for this drug.
Patients taking ANTI THYMOCYTE GLOBULIN (RABBIT) who experience drug ineffective should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
DRUG INEFFECTIVE is moderately reported among ANTI THYMOCYTE GLOBULIN (RABBIT) users, representing a notable but not dominant share of adverse events.
In addition to drug ineffective, the following adverse reactions have been reported for ANTI THYMOCYTE GLOBULIN (RABBIT):
The following drugs have also been linked to drug ineffective in FDA adverse event reports:
DRUG INEFFECTIVE has been reported as an adverse event in 490 FDA reports for ANTI THYMOCYTE GLOBULIN (RABBIT). This does not prove causation, but indicates an association observed in post-market surveillance data.
DRUG INEFFECTIVE accounts for approximately 3.1% of all adverse event reports for ANTI THYMOCYTE GLOBULIN (RABBIT), making it one of the most commonly reported side effect.
If you experience drug ineffective while taking ANTI THYMOCYTE GLOBULIN (RABBIT), contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.